Preliminary research also found that higher levels of PD-L1 expression and T cell subsets regulation in non-responders to platinum-based neoadjuvant chemotherapy, suggesting the benefit for combined immunotherapy and chemotherapy (refer to chemoimmunotherapy) prior to surgical resection of locally advanced NSCLC [8]. The gene discussed is CD274; the disease is non-small cell lung carcinoma.